These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 4301832)

  • 1. Inhibition of vasopressin-induced ACTH release from the pituitary by glucocorticoids in vitro.
    Fleischer N; Vale W
    Endocrinology; 1968 Dec; 83(6):1232-6. PubMed ID: 4301832
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of dexamethasone on ACTH release induced by lysine vasopressin in man; time interval between dexamethasone and vasopressin injection.
    Takebe K; Kunita H; Sakakura M; Horiuchi Y
    J Clin Endocrinol Metab; 1968 May; 28(5):644-50. PubMed ID: 4297476
    [No Abstract]   [Full Text] [Related]  

  • 3. Dexamethasone suppression of ACTH release: effect of the interval between steroid administration and the application of stimuli known to release ACTH.
    Sirett NE; Gibbs FP
    Endocrinology; 1969 Aug; 85(2):355-9. PubMed ID: 4306606
    [No Abstract]   [Full Text] [Related]  

  • 4. Stimulation of corticotropin release by corticotropin-releasing factor (CRF) or by vasopressin following intrapituitary infusions in unanesthetized dogs: inhibition of the responses by dexamethasone.
    Gonzalez-Luque A; L'age M; Dhariwal AP; Yates FE
    Endocrinology; 1970 May; 86(5):1134-42. PubMed ID: 4314067
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of corticotropin-releasing factor, dexamethasone and actinomycin D on the release of ACTH from rat pituitaries in vivo and in vitro.
    Arimura A; Bowers CY; Schally AV; Saito M; Miller MC
    Endocrinology; 1969 Aug; 85(2):300-11. PubMed ID: 4306603
    [No Abstract]   [Full Text] [Related]  

  • 6. Once-a-day neurally stimulated and basal ACTH secretion phases in man and their response to corticoid inhibition.
    Ceresa F; Angeli A; Boccuzzi G; Molino G
    J Clin Endocrinol Metab; 1969 Aug; 29(8):1074-82. PubMed ID: 4308414
    [No Abstract]   [Full Text] [Related]  

  • 7. Inhibition of adrenocorticotropic hormone production by glucocorticoids in mouse pituitary tumor cells.
    Watanabe H; Nicholson WE; Orth DN
    Endocrinology; 1973 Aug; 93(2):411-6. PubMed ID: 4352443
    [No Abstract]   [Full Text] [Related]  

  • 8. Studies on the glucocorticoid feedback control of ACTH secretion.
    Kendall JW; Allen C
    Endocrinology; 1968 Feb; 82(2):397-405. PubMed ID: 4378097
    [No Abstract]   [Full Text] [Related]  

  • 9. Inhibition by dexamethasone of the in vivo pituitary response to corticotropin-releasing factor (CRF).
    Russell SM; Dhariwal AP; McCann SM; Yates FE
    Endocrinology; 1969 Sep; 85(3):512-21. PubMed ID: 4307361
    [No Abstract]   [Full Text] [Related]  

  • 10. Role of calcium ions in the release of ACTH from rat pituitary tissue in vitro.
    Zimmerman G; Fleischer N
    Endocrinology; 1970 Aug; 87(2):426-9. PubMed ID: 4316575
    [No Abstract]   [Full Text] [Related]  

  • 11. The effects of corticotropin-releasing factor on adrenocorticotropin secretion from perifused pituitaries in vitro: rapid inhibition by glucocorticoids.
    Widmaier EP; Dallman MF
    Endocrinology; 1984 Dec; 115(6):2368-74. PubMed ID: 6094157
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ACTH synthesis and release in pituitary monolayer culture: effect of dexamethasone.
    Fleischer N; Rawls WE
    Am J Physiol; 1970 Aug; 219(2):445-8. PubMed ID: 4317600
    [No Abstract]   [Full Text] [Related]  

  • 13. The importance of stimulus intensity and duration of steroid administration in suppression of stress-induced ACTH secretion.
    Kendall JW; Egans ML; Stott AK; Kramer RM; Jacobs JJ
    Endocrinology; 1972 Feb; 90(2):525-30. PubMed ID: 4333137
    [No Abstract]   [Full Text] [Related]  

  • 14. Pituitary 45 Ca ion uptake and release of ACTH, GH, and TSH: effect of verapamil.
    Eto S; Wood JM; Hutchins M; Fleischer N
    Am J Physiol; 1974 Jun; 226(6):1315-20. PubMed ID: 4365294
    [No Abstract]   [Full Text] [Related]  

  • 15. [Metabolic balance studies during oral administration of Fluocortolone].
    Gillich KH; Krüskemper HL; Ködding R; Delbrück A
    Int Z Klin Pharmakol Ther Toxikol; 1968 Jan; 1(3):197-202. PubMed ID: 4301840
    [No Abstract]   [Full Text] [Related]  

  • 16. Increased pituitary sensitivity to glucocorticoid feedback during the stress nonresponsive period in the neonatal rat.
    Walker CD; Sapolsky RM; Meaney MJ; Vale WW; Rivier CL
    Endocrinology; 1986 Oct; 119(4):1816-21. PubMed ID: 3019645
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Control of bioactive corticotropin release from the neuro-intermediate lobe of the rat pituitary in vitro.
    Fischer JL; Moriarty CM
    Endocrinology; 1977 Apr; 100(4):1047-54. PubMed ID: 189989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pituitary-thyroid function of the rat after suppression of ACTH release by dexamethasone implants in the median eminence.
    Strashimirov D; Bohus B; Kovács S
    Acta Physiol Acad Sci Hung; 1969; 35(3):335-44. PubMed ID: 4311466
    [No Abstract]   [Full Text] [Related]  

  • 19. Changes in plasma 11-hydroxycorticosteroids after ACTH, insulin and dexamethasone in neonatal infants.
    Okuno A; Nishimura Y; Kawarazaki T
    J Clin Endocrinol Metab; 1972 Mar; 34(3):516-20. PubMed ID: 4334768
    [No Abstract]   [Full Text] [Related]  

  • 20. [Inhibitory mechanism of CRF-ACTH system].
    Ito S
    Horumon To Rinsho; 1970 May; 18(5):351-7. PubMed ID: 4317992
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.